Correlates of health-related quality of life in women with severe facial blemishes

International Journal of Dermatology

Volumn 45, Issue 2, 2006, Pages 111-115

  Balkrishnan, Rajesh ^a,b,c,d   McMichael, Amy J ^a,b,c   Hu, Judy Y ^a,b,c   Camacho, Fabian T ^a,b,c   Shew, Katherine R ^a,b,c   Bouloc, Anne ^a,b,c   Rapp, Stephen R ^a,b,c   Feldman, Steven R ^a,b,c  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^c Tarnier Hospital   (France)

^d UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACNE; ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; ARTICLE; CHLOASMA; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; DEPENDENT VARIABLE; DISEASE ASSOCIATION; DISEASE SEVERITY; FACE; FEMALE; HUMAN; HYPOPIGMENTATION; LENTIGO; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; NEVUS FLAMMEUS; PAPULOSIS; PREDICTOR VARIABLE; QUALITY OF LIFE; ROSACEA; SCAR FORMATION; SELF CONCEPT; SKIN DEFECT; VASCULAR LESION; VISUAL ANALOG SCALE;

ADOLESCENT; ADULT; COSMETICS; FACIAL DERMATOSES; FEMALE; HUMANS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NORTH CAROLINA; QUALITY OF LIFE; QUESTIONNAIRES; SELF CONCEPT; SEVERITY OF ILLNESS INDEX; WOMEN;

EID: 33645999675     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2004.02371.x     Document Type: Article

References (18)

1. Roberts NC. Corrective cosmetics: Need, evaluation and use. Cutis 1988; 41: 439-441.
2. Dixon JA, Rotering RH, Huether SE. Patient's evaluation of argon laser therapy of port wine stain, decorative tattoo, and essential telangiectasia. Lasers Surg Med 1984; 4: 181-190.
3. Lanigan S, Cotterill JA. Psychological disabilities amongst patients with port wine stains. Br J Dermatol 1989; 121: 209-215.
4. Lanigan S. The stigma of port wine stains. Br J Hospital Med 1991; 45: 274-276.
5. Porter J, Beuf AH, Lerner A, et al. Psychosocial effect of vitiligo: A comparison of vitiligo patients with "normal"control subjects, with psoriasis patients, and with patients with other pigmentary disorders. J Am Acad Dermatol 1986; 15: 220-224.
6. Porter J, Beuf A, Nordlund JJ, et al. Personal responses of patients to vitiligo: The importance of the patient-physician interaction. Arch Dermatol 1978; 114: 1384-1385.
7. Porter J, Beuf AH, Lerner A, et al. Response to cosmetic disfigurement: patients with vitiligo. Cutis 1987; 39: 493-494.
8. Porter J, Beuf AH, Lerner A, et al. The effect of vitiligo on sexual relationships. J Am Acad Dermatol 1990; 22: 221-222.
9. Anderson RT, Rajagopalan R. Development and validation of a quality of life instrument for cutaneous diseases. J Am Acad Dermatol 1997; 37: 41-50.
10. Finlay AY. Quality of life measurement in dermatology: A practical guide. Br J Dermatol 1997; 136: 305-314.
11. Chren MM, Lasek RJ, Sahay AP, et al. Measurement properties of Skindex-16: A brief quality-of-life measure for patients with skin diseases. J Cutan Med Surg 2001; 5: 105-110.
12. Chren MM, Lasek RJ, Quinn LM, et al. Skindex, a quality-of-life measure for patients with skin disease. reliability, validity, and responsiveness. J Invest Dermatol 1996; 107: 707-713.
13. Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI) - a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210-216.
14. Kimbrough-Green CK, Griffiths CE, Finkel LJ, et al. Topical retinoic acid (tretinoin) for melasma in black patients. A vehicle-controlled clinical trial. Arch Dermatol 1994; 130: 727-733.
15. Leary MR, Rapp SR, Herbst KC, et al. Interpersonal concerns and psychological difficulties of psoriasis patients: Effects of disease severity and fear of negative evaluation. Health Psychol 1998; 17: 530-536.
16. Rapp SR, Cottrell CA, Leary MR. Social coping strategies associated with quality of life decrements among psoriasis patients. Br J Dermatol 2001; 145: 610-616.
17. Greene WH. Econometric Analysis, 3rd edn. Englewood Cliffs, NJ: Prentice Hall, 1998.
18. STATA Statistical Software. Release 5.0. College Station, TX.